Related Experiment Video

Updated: Jun 24, 2026

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
07:43

A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

Published on: July 14, 2023

Preclinical screening of gene therapy in human tissues

Leonard W Seymour, Kerry D Fisher

    Human Gene Therapy
    |April 7, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
    09:13

    Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

    Published on: October 24, 2016

    Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
    11:16

    Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

    Published on: February 15, 2019

    Related Experiment Videos

    Last Updated: Jun 24, 2026

    A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears
    07:43

    A Validatable Droplet Digital Polymerase Chain Reaction Assay for the Detection of Adeno-Associated Viral Vectors in Bioshedding Studies of Tears

    Published on: July 14, 2023

    Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
    09:13

    Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

    Published on: October 24, 2016

    Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
    11:16

    Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

    Published on: February 15, 2019

    Related Concept Videos

    Gene Therapy00:59

    Gene Therapy

    Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
    Genetic Screens02:46

    Genetic Screens

    Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
    Forward genetic screens
    Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
    In-vitro Mutagenesis01:16

    In-vitro Mutagenesis

    To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

    Articles linked to this work by shared authors, journal, and citation graph.

    Hypoxia increases the activity of oncolytic adenoviruses through HIF-2α-stimulated E1A expression.

    Signal transduction and targeted therapy·2026

    T cell engagers: expanding horizons in oncology and beyond.

    British journal of cancer·2025

    The implications of oncolytic viruses targeting fibroblasts in enhancing the antitumoural immune response.

    Heliyon·2024

    Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells.

    Journal for immunotherapy of cancer·2024

    AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes.

    Scientific reports·2023

    Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent?

    Journal for immunotherapy of cancer·2023

    Engineering Human Hematopoietic Stem and Progenitor Cells for Antigen Expression in Antigen-Presenting Cells.

    Human gene therapy·2026

    Triple-Target CRISPR Strategy to Block HIV Entry and Replication in Permissive Cells.

    Human gene therapy·2026

    Perivascular Astrocytic Gliosis Induced by Retinal Gene Therapy.

    Human gene therapy·2026

    Durational Study of Persistent Transduction of Rhesus Macaque Lung and Other Organs Following Single Dosing with AAV1-CFTR.

    Human gene therapy·2026

    Real-World Data from a Single-Center, Large Academic Centralized Manufacturing of CD19 CAR T Cells in an Industry Partnership.

    Human gene therapy·2026

    Streamlining Genetically Modified Organism Regulatory Classification in UK Gene Therapy Clinical Trials: A UK Pharmacy Perspective.

    Human gene therapy·2026

    [Development of universal off-the-shelf T cell therapies derived from ES/iPS cells for leukemia and COVID-19].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    [Intrathecal immunoglobulin administration for refractory viral central nervous system infection after allogeneic hematopoietic stem cell transplantation].

    [Rinsho ketsueki] The Japanese journal of clinical hematology·2026

    Effect of Vutrisiran According to Baseline Tafamidis Use in Transthyretin Amyloidosis With Cardiomyopathy: Insights From HELIOS-B.

    Journal of the American College of Cardiology·2026

    Gene Silencer Therapy in Transthyretin Amyloid Cardiomyopathy: A Meta-Analysis of Outcomes Trials.

    JAMA·2026

    Advanced therapy medicinal products in Saudi Arabia: Regulation and development.

    Regenerative therapy·2026

    289th ENMC international workshop: assessing and managing emerging AAV related toxicities after gene therapy for neuromuscular disorders, 26 - 28 September 2025, Hoofddorp, The Netherlands.

    Neuromuscular disorders : NMD·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us